Author: Hamilton-Craig Ian Kostner Karam Maximilien Woodhouse Stan Colquhoun David
Publisher: Blackwell Publishing
ISSN: 1744-1595
Source: International Journal of Evidence-based Healthcare, Vol.10, Iss.3, 2012-09, pp. : 181-190
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice
By Morovat Alireza Weerasinghe Gayani Nesbitt Victoria Hofer Monika Agnew Thomas Quaghebeur Geralrine Sergeant Kate Fratter Carl Guha Nishan Mirzazadeh Mehdi Poulton Joanna
Journal of Clinical Medicine, Vol. 6, Iss. 8, 2017-08 ,pp. :
By Schwartzberg L. Shiffman R. Tomita D. Stolshek B. Rossi G. Adamson R.
Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. :
Therapy for -Antitrypsin Deficiency: Pharmacology and Clinical Recommendations
BioDrugs, Vol. 13, Iss. 2, 2000-02 ,pp. :